- Just 3% of all Covid vaccine doses went to Africa, which has one-fifth of the world’s population. (NYT)
- VA health record system: Errors delay medication and treatment, endangering more than 40,000 patients.
- Paul Krugman in 2006: The VA “has been able to take the lead in electronic record-keeping and other innovations that reduce costs.”
- Kaiser study: Value of the tax exemption for nonprofit hospitals: $28.1 billion. Value of charity care: $16.0 Billion.
- Dylan Matthews: against work requirements for Medicaid.
Category: News and Events
George Halvorson on Amputations: Medicare v. MA Plans
Medicare Patients are currently 10 times more likely to have amputations than higher income patients. Those amputations currently cost Medicare over $100,000 each…. The Medicare Advantage plans do basic care process design to help those patients. The Medicare Advantage care teams know that almost 90 percent of amputations are caused by foot ulcers. The plans all know…
Nurses Join the Gig Economy
Hospitals are becoming part of the Gig Economy as administrators turn to staffing apps to fill shifts when internal staffing is low. The transition to more temporary nurses is fueled by a shortage that has given nurses more control over their schedule. Nurses are turning to the apps to manage when they work or pick up extra shifts as the gig work invades hospitals like it has other areas of the economy.
Friday Links
- Health Savings Accounts after 30 years: 27.5 million individuals own one, with holdings of $105.7 billion.
- Three Medicaid reforms Biden doesn’t like: Trump era work requirements, the Tennessee block grant and the Texas waiver.
- What white bagging, brown bagging and clear bagging have to do with specialty drugs.
- A Crenshaw/Schrier House bill would give Medicaid enrollees access to direct primary care doctors.
- Insurers are using “copay accumulators” to prevent copay assistance (say, from a nonprofit to help patients with drugs costs) for counting toward the fulfillment of a deductible.
- The Biden administration is misusing the “march in rights” created under the Bayh-Dole Act to threaten to impose price controls on drugs that originally had government research funding. (WSJ)